0.6399
+0.0091
+(1.44%)
At close: January 13 at 4:00:00 PM EST
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
--
17,373.0000
41,079.0000
19,605.0000
Total Liabilities Net Minority Interest
--
10,394.0000
10,907.0000
9,886.0000
Total Equity Gross Minority Interest
--
6,979.0000
30,172.0000
9,719.0000
Total Capitalization
--
9,294.0000
32,890.0000
13,196.0000
Common Stock Equity
--
6,979.0000
30,172.0000
9,719.0000
Capital Lease Obligations
--
349.0000
409.0000
432.0000
Net Tangible Assets
--
6,979.0000
30,172.0000
9,719.0000
Working Capital
--
10,782.0000
32,165.0000
12,603.0000
Invested Capital
--
10,461.0000
33,870.0000
14,452.0000
Tangible Book Value
--
6,979.0000
30,172.0000
9,719.0000
Total Debt
--
3,831.0000
4,107.0000
5,165.0000
Share Issued
10,645.0490
8,306.3260
7,475.9160
6,974.6580
Ordinary Shares Number
10,645.0490
8,306.3260
7,475.9160
6,974.6580
12/31/2020 - 10/2/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
IDXG Interpace Biosciences, Inc.
0.6200
+10.60%
EDTXF Spectral Medical Inc.
0.3730
0.00%
PRE Prenetics Global Limited
5.88
+8.09%
MYGN Myriad Genetics, Inc.
14.28
-3.71%
SONA.CN Sona Nanotech Inc.
0.2550
-1.92%
BDSX Biodesix, Inc.
1.2400
-2.36%
CDNA CareDx, Inc
25.07
+6.09%
PRPH ProPhase Labs, Inc.
0.6490
0.00%
ACRS Aclaris Therapeutics, Inc.
2.4800
+0.40%
BIAF bioAffinity Technologies, Inc.
0.7547
-6.83%